Chromosomal instability and bladder cancer: the <scp>UroVysion</scp> <sup>TM</sup> test in the <scp>UroScreen</scp> study

Bonberg, Nadine; Taeger, Dirk; Gawrych, Katarzyna; Johnen, Georg; Banek, Séverine; Schwentner, Christian; Sievert, Karl‐Dietrich; Wellhäußer, Harald; Kluckert, Matthias; Leng, G.; Nasterlack, Michael; Stenzl, Arnulf; Behrens, Thomas; Brüning, Thomas; Pesch, Beate; UroScreen Study Group, The

doi:10.1111/j.1464-410x.2012.11666.x

Public

Chromosomal instability and bladder cancer: the UroVysion TM test in the UroScreen study

Published in British Journal of Urology • Jan 25, 2013

Authors:

Nadine Bonberg

Dirk Taeger

Katarzyna Gawrych

Abstract

UNLABELLED: What's known on the subject? and what does the study add?: UroVysion™ is a multicolour fluorescence in situ hybridisation assay that detects DNA gain at chromosomes 3, 7 and 17 and loss at the 9p21 locus in exfoliated urothelial cells. This cell-based test is time-consuming and costly co...

Subject

Bladder cancer

Polysomy

Locus (genetics)

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!